CompletedNot Applicable

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France

France275 participantsStarted 2009-02

Plain-language summary

The purpose of this study is to describe common treatment pathways, to collect health care utilization data and to assess symptom load as well as impact of symptoms on daily life in GERD patients who are partial-responders to PPI treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * At least 6 month history of GERD symptoms * Treated with unchanged optimized PPI treatment for any GERD indication during the last 4 weeks before enrollment * Remaining GERD symptoms despite optimized PPI treatment * Able to read and write in French, and able to comply with study requirements Exclusion Criteria: * Patients that have not experienced any GERD symptom improvement at all during PPI treatment * Involvement in the planning or conduct of the study * Involvement in any other observational study or in any clinical study at the time of this study or during the last 6 months * Prior surgery of the upper GI tract

What they're measuring

Productivity loss; Frequency and severity of GERD symptoms; Health care resource use

Timeframe: Collected at enrollment visit and at 3, 6, 9 and 12 month follow-up. (Health care resource use is collected by the physician at enrollment visit and 6 and 12 month follow-up)

Utility values; Quality of Life

Timeframe: Collected at enrollment visit and at 6 and 12 month follow-up.

Trial details

NCT IDNCT00842855

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2010-11

View on ClinicalTrials.gov More Gastroesophageal Reflux Disease trials